Jim Green is a problem solver.
As a senior director of engineering for Bayer, Green and his colleagues work to design and deploy process equipment that consistently and efficiently manufactures biotherapeutics. Their latest challenge: develop scalable and automated equipment that produces cutting-edge cell therapies.
Bayer’s allogeneic cell therapy innovation engine, BlueRock Therapeutics, has an early R&D pipeline of exciting candidates. BlueRock’s portfolio is part of roughly 1,300 industry-wide…
